ABBV vs AEVAW · P/E 81, rev $16.99B vs rev $9.1M
AbbVie Inc (ABBV) versus Aeva Technologies, Inc. Warrants (AEVAW) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Aeva Technologies, Inc. Warrants (AEVAW) is a software - infrastructure company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported AEVAW revenue for 2024-12-31 was $9.1M. Net income was -$152.3M. Revenue was up 110.2% from 2023-12-31 to 2024-12-31. AEVAW currently screens at market cap $0.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. AEVAW currently screens at market cap $0.
Not investment advice. Open the ABBV and AEVAW stock pages for the full models.
Not investment advice.